- Home
- HP vs CDTX Comparison
HP vs CDTX Comparison
Compare HP & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- CDTX
- Stock Information
- Founded
- HP 1920
- CDTX 2012
- Country
- HP United States
- CDTX United States
- Employees
- HP N/A
- CDTX N/A
- Industry
- HP Oil & Gas Production
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HP Energy
- CDTX Health Care
- Exchange
- HP Nasdaq
- CDTX Nasdaq
- Market Cap
- HP 1.6B
- CDTX 1.7B
- IPO Year
- HP N/A
- CDTX 2015
- Fundamental
- Price
- HP $20.20
- CDTX $63.17
- Analyst Decision
- HP Hold
- CDTX Strong Buy
- Analyst Count
- HP 11
- CDTX 11
- Target Price
- HP $22.20
- CDTX $57.00
- AVG Volume (30 Days)
- HP 2.1M
- CDTX 441.1K
- Earning Date
- HP 08-06-2025
- CDTX 11-06-2025
- Dividend Yield
- HP 4.95%
- CDTX N/A
- EPS Growth
- HP N/A
- CDTX N/A
- EPS
- HP N/A
- CDTX N/A
- Revenue
- HP $3,428,058,000.00
- CDTX N/A
- Revenue This Year
- HP $38.18
- CDTX N/A
- Revenue Next Year
- HP $4.65
- CDTX N/A
- P/E Ratio
- HP N/A
- CDTX N/A
- Revenue Growth
- HP 25.92
- CDTX N/A
- 52 Week Low
- HP $14.65
- CDTX $10.14
- 52 Week High
- HP $37.46
- CDTX $69.36
- Technical
- Relative Strength Index (RSI)
- HP 61.83
- CDTX 51.89
- Support Level
- HP $19.50
- CDTX $60.97
- Resistance Level
- HP $21.29
- CDTX $67.00
- Average True Range (ATR)
- HP 0.81
- CDTX 3.42
- MACD
- HP 0.17
- CDTX -0.72
- Stochastic Oscillator
- HP 72.68
- CDTX 35.25
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.